Company Announcement Net sales of DARZALEX® in the second quarter of 2024 totaled USD 2,878 millionGenmab receives royalties on worldwide…
BASEL, Switzerland – 17th July 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer…
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION17 JULY 2024 at 8.30 EEST Inside information: Phase III ARANOTE…
In a release issued under the same headline on July 12, 2024 by Onco360 Oncology Pharmacy, please note the change…
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients…
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical…
CHICAGO, July 16, 2024 /PRNewswire/ -- The global radiation detection, monitoring, and safety market, valued at USD 2.9 billion in…
COPENHAGEN, Denmark, July 16, 2024 /PRNewswire/ -- Synamics Therapeutics, a groundbreaking AI-driven drug discovery startup dedicated to combating drug resistance…
See the VELA Mammography Chair in action for the first time in Booth 208 at the Florida Radiological Association and…
Live video webcast with Chief Executive Officer, John Climaco, on Wednesday, June 17th at 4:00 PM ET HOUSTON, TX /…